Cervix carcinoma is an important health problem world-wide, being the secon
d most common cancer among women, ranking first in many developing countrie
s. A number of important epidemiological risk factors have been identified
as contributing to the development of CIN and invasive cervix carcinoma. Of
key importance is infection with human papillomavirus (HPV), which is the
primary risk factor. There are evolving primary and secondary preventive st
rategies that could further reduce the burden from cervical carcinoma. The
possible primary preventive strategies include risk reduction, diet or diet
ary supplements, HPV vaccines, and other chemopreventive agents. The possib
le advances in secondary preventive strategies include new technologies for
Pap smears. HPV typing triage, and other adjuvant screening procedures, Th
e impact of these strategies will depend upon evidence to support their use
along with the characteristics of the population and environment in which
they are used. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.